{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:37:58Z","timestamp":1787161078745,"version":"build-2736575974"},"reference-count":258,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Due to the limited accessibility of the in vivo situation, the scarcity of the human tissue, legal constraints, and ethical considerations, the underlying molecular mechanisms of disorders, such as preeclampsia, the pathological consequences of fetomaternal microchimerism, or infertility, are still not fully understood. And although substantial progress has already been made, the therapeutic strategies for reproductive system diseases are still facing limitations. In the recent years, it became more and more evident that stem cells are powerful tools for basic research in human reproduction and stem cell-based approaches moved into the center of endeavors to establish new clinical concepts. Multipotent fetal stem cells derived from the amniotic fluid, amniotic membrane, chorion leave, Wharton\u00b4s jelly, or placenta came to the fore because they are easy to acquire, are not associated with ethical concerns or covered by strict legal restrictions, and can be banked for autologous utilization later in life. Compared to adult stem cells, they exhibit a significantly higher differentiation potential and are much easier to propagate in vitro. Compared to pluripotent stem cells, they harbor less mutations, are not tumorigenic, and exhibit low immunogenicity. Studies on multipotent fetal stem cells can be invaluable to gain knowledge on the development of dysfunctional fetal cell types, to characterize the fetal stem cells migrating into the body of a pregnant woman in the context of fetomaternal microchimerism, and to obtain a more comprehensive picture of germ cell development in the course of in vitro differentiation experiments. The in vivo transplantation of fetal stem cells or their paracrine factors can mediate therapeutic effects in preeclampsia and can restore reproductive organ functions. Together with the use of fetal stem cell-derived gametes, such strategies could once help individuals, who do not develop functional gametes, to conceive genetically related children. Although there is still a long way to go, these developments regarding the usage of multipotent fetal stem cells in the clinic should continuously be accompanied by a wide and detailed ethical discussion.<\/jats:p>","DOI":"10.1186\/s13287-023-03379-4","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T14:02:33Z","timestamp":1686146553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Multipotent fetal stem cells in reproductive biology research"],"prefix":"10.1186","volume":"14","author":[{"given":"Margit","family":"Rosner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Horer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Feichtinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3342-7583","authenticated-orcid":false,"given":"Markus","family":"Hengstschl\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"3379_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0092-8674(00)81692-X","volume":"100","author":"IL Weissman","year":"2000","unstructured":"Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000;100:157\u201368.","journal-title":"Cell"},{"key":"3379_CR2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.5966\/sctm.2013-0194","volume":"3","author":"M Rosner","year":"2014","unstructured":"Rosner M, Schipany K, Hengstschl\u00e4ger M. The decision on the \u201coptimal\u201d human pluripotent stem cell. Stem Cells Transl Med. 2014;3:553\u20139.","journal-title":"Stem Cells Transl Med"},{"key":"3379_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/humupd\/dmaa027","volume":"26","author":"AM Pereira Daoud","year":"2020","unstructured":"Pereira Daoud AM, Popovic M, Dondorp WJ, Trani Bustos M, Bredenoord AL, de Chuva Sousa Lopes SM, et al. Modelling human embryogenesis: embryo-like structures spark ethical and policy debate. Hum Reprod Update. 2020;26:779\u201398.","journal-title":"Hum Reprod Update"},{"key":"3379_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.stem.2019.06.010","volume":"25","author":"A Yilmaz","year":"2019","unstructured":"Yilmaz A, Benvenisty N. Defining human pluripotency. Cell Stem Cell. 2019;25:9\u201322.","journal-title":"Cell Stem Cell"},{"key":"3379_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell. 2020;27:523\u201331.","journal-title":"Cell Stem Cell"},{"key":"3379_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.stem.2019.10.001","volume":"25","author":"M Desgres","year":"2019","unstructured":"Desgres M, Menasch\u00e9 P. Clinical translation of pluripotent stem cell therapies: challenges and considerations. Cell Stem Cell. 2019;25:594\u2013606.","journal-title":"Cell Stem Cell"},{"key":"3379_CR7","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1172\/JCI138645","volume":"130","author":"M Donowitz","year":"2020","unstructured":"Donowitz M, Turner JR, Verkam AS, Zachos NC. Current and potential future applications of human stem cell models in drug development. J Clin Invest. 2020;130:3342\u20134.","journal-title":"J Clin Invest"},{"key":"3379_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-020-0064-x","volume":"19","author":"EA Kimbrel","year":"2020","unstructured":"Kimbrel EA, Lanza R. Next-generation stem cells - ushering in a new era of cell-based therapies. Nat Rev Drug Discov. 2020;19:463\u201379.","journal-title":"Nat Rev Drug Discov"},{"key":"3379_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.stem.2020.02.011","volume":"26","author":"A Sharma","year":"2020","unstructured":"Sharma A, Sances S, Workman MJ, Svendsen CN. Multi-lineage human iPSC derived platforms for disease modeling and drug discovery. Cell Stem Cell. 2020;26:309\u201329.","journal-title":"Cell Stem Cell"},{"key":"3379_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1161\/CIRCRESAHA.118.314287","volume":"124","author":"MZ Ratajczak","year":"2019","unstructured":"Ratajczak MZ, Ratajczak J, Kucia M. Very small embryonic-like stem cells (VSELs). Circ Res. 2019;124:208\u201310.","journal-title":"Circ Res"},{"key":"3379_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humupd\/dmw030","volume":"23","author":"D Bhartiya","year":"2016","unstructured":"Bhartiya D, Shaikh A, Anand S, Patel H, Kapoor S, Sriraman K, et al. Endogenous, very small embryonic-like stem cells: critical review, therapeutic potential and a look ahead. Hum Reprod Update. 2016;23:41\u201376.","journal-title":"Hum Reprod Update"},{"key":"3379_CR12","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726\u201336.","journal-title":"Nat Rev Immunol"},{"key":"3379_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"3379_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","volume":"21","author":"S Viswanathan","year":"2019","unstructured":"Viswanathan S, Shi Y, Galipeau J, Krampera M, Leblanc K, Martin I, et al. Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT\u00ae) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy. 2019;21:1019\u201324.","journal-title":"Cytotherapy"},{"key":"3379_CR15","doi-asserted-by":"publisher","first-page":"610544","DOI":"10.3389\/fbioe.2020.610544","volume":"8","author":"AR Silini","year":"2020","unstructured":"Silini AR, Di Pietro R, Lang-Olip I, Alviano F, Banerjee A, Basile M, et al. Perinatal derivatives: where do we stand? A roadmap of the human placenta and consensus for tissue and cell momenclature. Front Bioeng Biotechnol. 2020;8:610544.","journal-title":"Front Bioeng Biotechnol"},{"key":"3379_CR16","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/humrep\/deg279","volume":"18","author":"AR Prusa","year":"2003","unstructured":"Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschl\u00e4ger M. Oct-4 expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod. 2003;18:1489\u201393.","journal-title":"Hum Reprod"},{"key":"3379_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nbt1274","volume":"25","author":"P De Coppi","year":"2007","unstructured":"De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotech. 2007;25:100\u20136.","journal-title":"Nat Biotech"},{"key":"3379_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1634\/stemcells.2007-0594","volume":"26","author":"O Parolini","year":"2008","unstructured":"Parolini O, Alviano F, Bagnara GP, Bilic G, B\u00fchring HJ, Evangelista M, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells. 2008;26:300\u201311.","journal-title":"Stem Cells"},{"key":"3379_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.placenta.2017.04.008","volume":"59","author":"C Balbi","year":"2017","unstructured":"Balbi C, Bollini S. Fetal and perinatal stem cells in cardiac regeneration: Moving forward to the paracrine era. Placenta. 2017;59:96\u2013106.","journal-title":"Placenta"},{"key":"3379_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/genes12010006","volume":"12","author":"P de la Torre","year":"2020","unstructured":"de la Torre P, Flores AI. Current status and future prospects of perinatal stem cells. Genes (Basel). 2020;12:6.","journal-title":"Genes (Basel)"},{"key":"3379_CR21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1055\/s-2006-952149","volume":"24","author":"PV Guillot","year":"2006","unstructured":"Guillot PV, O\u2019Donoghue K, Kurata H, Fisk NM. Fetal stem cells: betwixt and between. Semin Reprod Med. 2006;24:340\u20137.","journal-title":"Semin Reprod Med"},{"key":"3379_CR22","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1182\/blood.V98.8.2396","volume":"98","author":"C Campagnoli","year":"2001","unstructured":"Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem\/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001;98:2396\u2013402.","journal-title":"Blood"},{"key":"3379_CR23","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood.V99.5.1870","volume":"99","author":"PA Taylor","year":"2002","unstructured":"Taylor PA, McElmurry RT, Lees CJ, Harrison DE, Blazar BR. Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients. Blood. 2002;99:1870\u20132.","journal-title":"Blood"},{"key":"3379_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1432-0436.2005.00019.x","volume":"73","author":"S Nava","year":"2005","unstructured":"Nava S, Westgren M, Jaksch M, Tibell A, Broom\u00e9 U, Ericzon BG, et al. Characterization of cells in the developing human liver. Differentiation. 2005;73:249\u201360.","journal-title":"Differentiation"},{"key":"3379_CR25","first-page":"845","volume":"88","author":"WA Noort","year":"2003","unstructured":"Noort WA, Scherjon SA, Kleijburg-van der Keur C, Kruisselbrink AB, van Bezooijen RL, et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica. 2003;88:845\u201352.","journal-title":"Haematologica"},{"key":"3379_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0022-2143(03)00022-2","volume":"141","author":"Y Hu","year":"2003","unstructured":"Hu Y, Liao L, Wang Q, Ma L, Ma G, Jiang X, et al. Isolation and identification of mesenchymal stem cells from human fetal pancreas. J Lab Clin Med. 2003;141:342\u20139.","journal-title":"J Lab Clin Med"},{"key":"3379_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/01.LAB.0000062890.40534.1C","volume":"83","author":"H Huang","year":"2003","unstructured":"Huang H, Tang X. Phenotypic determination and characterization of nestin-positive precursors derived from human fetal pancreas. Lab Invest. 2003;83:539\u201347.","journal-title":"Lab Invest"},{"key":"3379_CR28","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/S0301-472X(02)00967-0","volume":"30","author":"G Almeida-Porada","year":"2002","unstructured":"Almeida-Porada G, El Shabrawy D, Porada C, Zanjani ED. Differentiative potential of human metanephric mesenchymal cells. Exp Hematol. 2002;30:1454\u201362.","journal-title":"Exp Hematol"},{"key":"3379_CR29","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.bpobgyn.2004.06.010","volume":"18","author":"K O'Donoghue","year":"2004","unstructured":"O\u2019Donoghue K, Fisk NM. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol. 2004;18:853\u201375.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"3379_CR30","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1582-4934.2008.00221.x","volume":"12","author":"AJ Marcus","year":"2008","unstructured":"Marcus AJ, Woodbury D. Fetal stem cells from extra-embryonic tissues: do not discard. J Cell Mol Med. 2008;12:730\u201342.","journal-title":"J Cell Mol Med"},{"key":"3379_CR31","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2217\/rme-2017-0066","volume":"12","author":"PS Couto","year":"2017","unstructured":"Couto PS, Bersenev A, Verter F. The first decade of advanced cell therapy clinical trials using perinatal cells (2005\u20132015). Regen Med. 2017;12:953\u201368.","journal-title":"Regen Med"},{"key":"3379_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2020.04.035","volume":"110","author":"IA Deus","year":"2020","unstructured":"Deus IA, Mano JF, Cust\u00f3dio CA. Perinatal tissues and cells in tissue engineering and regenerative medicine. Acta Biomater. 2020;110:1\u201314.","journal-title":"Acta Biomater"},{"key":"3379_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13287-021-02158-3","volume":"12","author":"C Yang","year":"2021","unstructured":"Yang C, Wu M, You M, Chen Y, Luo M, Chen Q. The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases. Stem Cell Res Ther. 2021;12:103.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2217\/rme.09.12","volume":"4","author":"KI Pappa","year":"2009","unstructured":"Pappa KI, Anagnou NP. Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med. 2009;4:423\u201333.","journal-title":"Regen Med"},{"key":"3379_CR35","doi-asserted-by":"publisher","first-page":"S689","DOI":"10.1098\/rsif.2010.0347.focus","volume":"7","author":"H Abdulrazzak","year":"2010","unstructured":"Abdulrazzak H, Moschidou D, Jones G, Guillot PV. Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface. 2010;7:S689-706.","journal-title":"J R Soc Interface"},{"key":"3379_CR36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1387\/ijdb.092935md","volume":"54","author":"MP Dobreva","year":"2010","unstructured":"Dobreva MP, Pereira PNG, Deprest J, Zwijsen A. On the origin of amniotic stem cells: of mice and men. Int J Dev Biol. 2010;54:761\u201377.","journal-title":"Int J Dev Biol"},{"key":"3379_CR37","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1089\/scd.2012.0637","volume":"22","author":"R Calloni","year":"2013","unstructured":"Calloni R, Cordero EA, Henriques JA, Bonatto D. Reviewing and updating the major molecular markers for stem cells. Stem Cells Dev. 2013;22:1455\u201376.","journal-title":"Stem Cells Dev"},{"key":"3379_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bpobgyn.2015.07.006","volume":"31","author":"MS Joerger-Messerli","year":"2016","unstructured":"Joerger-Messerli MS, Marx C, Oppliger B, Mueller M, Surbek DV, Schoeberlein A. Mesenchymal stem cells from Wharton\u2019s Jelly and amniotic fluid. Best Pract Res Clin Obstet Gynaecol. 2016;31:30\u201344.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"3379_CR39","doi-asserted-by":"publisher","DOI":"10.2174\/1574888X16666211210143640","author":"M Rosner","year":"2021","unstructured":"Rosner M, Hengstschl\u00e4ger M. Amniotic fluid stem cells: what they are and what they can become. Curr Stem Cell Res Ther. 2021. https:\/\/doi.org\/10.2174\/1574888X16666211210143640.","journal-title":"Curr Stem Cell Res Ther"},{"key":"3379_CR40","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nprot.2010.74","volume":"5","author":"M Rosner","year":"2010","unstructured":"Rosner M, Siegel N, Fuchs C, Slabina N, Dolznig H, Hengstschl\u00e4ger M. Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells. Nat Protoc. 2010;5:1081\u201395.","journal-title":"Nat Protoc"},{"key":"3379_CR41","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/onc.2009.405","volume":"29","author":"A Valli","year":"2010","unstructured":"Valli A, Rosner M, Fuchs C, Siegel N, Bishop CE, Dolznig H, et al. Embryoid body formation of human amniotic fluid stem cells depends on mTOR. Oncogene. 2010;29:966\u201377.","journal-title":"Oncogene"},{"key":"3379_CR42","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1038\/mt.2012.117","volume":"20","author":"D Moschidou","year":"2012","unstructured":"Moschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, Abdulrazzak H, et al. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther. 2012;20:1953\u201367.","journal-title":"Mol Ther"},{"key":"3379_CR43","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1634\/stemcells.2005-0521","volume":"24","author":"CC Chien","year":"2006","unstructured":"Chien CC, Yen BL, Lee FK, Lai TH, Chen YC, Chan SH, et al. In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Stem Cells. 2006;24:1759\u201368.","journal-title":"Stem Cells"},{"key":"3379_CR44","doi-asserted-by":"publisher","first-page":"e6913","DOI":"10.1371\/journal.pone.0006913","volume":"4","author":"MY Lee","year":"2009","unstructured":"Lee MY, Huang JP, Chen YY, Aplin JD, Wu YH, Chen CY, et al. Angiogenesis in differentiated placental multipotent mesenchymal stromal cells is dependent on integrin alpha5beta1. PLoS One. 2009;4:e6913.","journal-title":"PLoS One"},{"key":"3379_CR45","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/jcb.22873","volume":"111","author":"MJ Lee","year":"2010","unstructured":"Lee MJ, Jung J, Na KH, Moon JS, Lee HJ, Kim JH, et al. Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl(4)-injured liver: potential application to the treatment of hepatic diseases. J Cell Biochem. 2010;111:1453\u201363.","journal-title":"J Cell Biochem"},{"key":"3379_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00441-011-1249-8","volume":"346","author":"MJ Kim","year":"2011","unstructured":"Kim MJ, Shin KS, Jeon JH, Lee DR, Shim SH, Kim JK, et al. Human chorionic-plate-derived mesenchymal stem cells and Wharton\u2019s jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells. Cell Tissue Res. 2011;346:53\u201364.","journal-title":"Cell Tissue Res"},{"key":"3379_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13287-017-0757-1","volume":"9","author":"MS Ventura Ferreira","year":"2018","unstructured":"Ventura Ferreira MS, Bienert M, M\u00fcller K, Rath B, Goecke T, Opl\u00e4nder C, et al. Comprehensive characterization of chorionic villi-derived mesenchymal stromal cells from human placenta. Stem Cell Res Ther. 2018;9:28.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13287-018-1104-x","volume":"10","author":"J Ma","year":"2019","unstructured":"Ma J, Wu J, Han L, Jiang X, Yan L, Hao J, et al. Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord, and chorionic plate under serum-free condition. Stem Cell Res Ther. 2019;10:19.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR49","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.cr.7310043","volume":"16","author":"P Bossolasco","year":"2006","unstructured":"Bossolasco P, Montemurro T, Cova L, Zangrossi S, Calzarossa C, Buiatiotis S, et al. Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res. 2006;16:329\u201336.","journal-title":"Cell Res"},{"key":"3379_CR50","doi-asserted-by":"publisher","first-page":"5932706","DOI":"10.1155\/2017\/5932706","volume":"2017","author":"LS Spitzhorn","year":"2017","unstructured":"Spitzhorn LS, Rahman MS, Schwindt L, Ho HT, Wruck W, Bohndorf M, et al. Isolation and molecular characterization of amniotic fluid-derived mesenchymal stem cells obtained from Caesarean sections. Stem Cells Int. 2017;2017:5932706.","journal-title":"Stem Cells Int"},{"key":"3379_CR51","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1089\/clo.2007.0027","volume":"9","author":"J Kim","year":"2007","unstructured":"Kim J, Kang HM, Kim H, Kim MR, Kwon HC, Gye MC, et al. Ex vivo characteristics of human amniotic membrane-derived stem cells. Cloning Stem Cells. 2007;9:581\u201394.","journal-title":"Cloning Stem Cells"},{"key":"3379_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-213X-7-11","volume":"7","author":"F Alviano","year":"2007","unstructured":"Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol. 2007;7:11.","journal-title":"BMC Dev Biol"},{"key":"3379_CR53","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3727\/096368908786576507","volume":"17","author":"G Bilic","year":"2008","unstructured":"Bilic G, Zeisberger SM, Mallik AS, Zimmermann R, Zisch AH. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant. 2008;17:955\u201368.","journal-title":"Cell Transplant"},{"key":"3379_CR54","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ajog.2006.01.101","volume":"194","author":"CB Portmann-Lanz","year":"2006","unstructured":"Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, Malek A, Holzgreve W, et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol. 2006;194:664\u201373.","journal-title":"Am J Obstet Gynecol"},{"key":"3379_CR55","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jcyt.2017.03.001","volume":"19","author":"AB Ara\u00fajo","year":"2017","unstructured":"Ara\u00fajo AB, Salton GD, Furlan JM, Schneider N, Angeli MH, Laureano \u00c1M, et al. Comparison of human mesenchymal stromal cells from four neonatal tissues: amniotic membrane, chorionic membrane, placental decidua and umbilical cord. Cytotherapy. 2017;19:577\u201385.","journal-title":"Cytotherapy"},{"key":"3379_CR56","doi-asserted-by":"publisher","first-page":"101537","DOI":"10.1016\/j.scr.2019.101537","volume":"40","author":"L Chen","year":"2019","unstructured":"Chen L, Merkhan MM, Forsyth NR, Wu P. Chorionic and amniotic membrane-derived stem cells have distinct, and gestational diabetes mellitus independent, proliferative, differentiation, and immunomodulatory capacities. Stem Cell Res. 2019;40:101537.","journal-title":"Stem Cell Res"},{"key":"3379_CR57","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1182\/blood-2003-05-1670","volume":"103","author":"OK Lee","year":"2004","unstructured":"Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood. 2004;103:1669\u201375.","journal-title":"Blood"},{"key":"3379_CR58","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1634\/stemcells.2006-0286","volume":"25","author":"S Karahuseyinoglu","year":"2007","unstructured":"Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells. 2007;25:319\u201331.","journal-title":"Stem Cells"},{"key":"3379_CR59","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1634\/stemcells.2006-0709","volume":"25","author":"D Baksh","year":"2007","unstructured":"Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25:1384\u201392.","journal-title":"Stem Cells"},{"key":"3379_CR60","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1182\/blood.V43.3.357.357","volume":"43","author":"S Knudtzon","year":"1974","unstructured":"Knudtzon S. In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood. 1974;43:357\u201361.","journal-title":"Blood"},{"key":"3379_CR61","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/sctm.17-0075","volume":"6","author":"J Kurtzberg","year":"2017","unstructured":"Kurtzberg J. A history of cord blood banking and transplantation. Stem Cells Transl Med. 2017;6:1309\u201311.","journal-title":"Stem Cells Transl Med"},{"key":"3379_CR62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/jcm8010117","volume":"8","author":"KS Brown","year":"2019","unstructured":"Brown KS, Rao MS, Brown HL. The future state of newborn stem cell banking. J Clin Med. 2019;8:117.","journal-title":"J Clin Med"},{"key":"3379_CR63","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/j.1537-2995.2006.00839.x","volume":"46","author":"BL Pipes","year":"2006","unstructured":"Pipes BL, Tsang T, Peng SX, Fiederlein R, Graham M, Harris DT. Telomere length changes after umbilical cord blood transplant. Transfusion. 2006;46:1038\u201343.","journal-title":"Transfusion"},{"key":"3379_CR64","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10616-014-9796-y","volume":"67","author":"A Hordyjewska","year":"2015","unstructured":"Hordyjewska A, Popio\u0142ek \u0141, Horecka A. Characteristics of hematopoietic stem cells of umbilical cord blood. Cytotechnology. 2015;67:387\u201396.","journal-title":"Cytotechnology"},{"key":"3379_CR65","doi-asserted-by":"publisher","first-page":"418752","DOI":"10.1155\/2015\/418752","volume":"2015","author":"MD Kuchma","year":"2015","unstructured":"Kuchma MD, Kyryk VM, Svitina HM, Shablii YM, Lukash LL, Lobyntseva GS, et al. Comparative analysis of the hematopoietic progenitor cells from placenta, cord blood, and fetal liver, based on their immunophenotype. Biomed Res Int. 2015;2015:418752.","journal-title":"Biomed Res Int"},{"key":"3379_CR66","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/tan.12792","volume":"87","author":"A Ruggeri","year":"2016","unstructured":"Ruggeri A, Paviglianiti A, Gluckman E, Rocha V. Impact of HLA in cord blood transplantation outcomes. HLA. 2016;87:413\u201321.","journal-title":"HLA"},{"key":"3379_CR67","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1634\/stemcells.2004-0357","volume":"23","author":"T Miki","year":"2005","unstructured":"Miki T, Lehmann T, Cai H, Stolz DB, Strom SC. Stem cell characteristics of amniotic epithelial cells. Stem Cells. 2005;23:1549\u201359.","journal-title":"Stem Cells"},{"key":"3379_CR68","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1167\/iovs.04-0495","volume":"46","author":"H Li","year":"2005","unstructured":"Li H, Niederkorn JY, Neelam S, Mayhew E, Word RA, McCulley JP, et al. Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci. 2005;46:900\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3379_CR69","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1097\/01.ico.0000247214.31757.5c","volume":"25","author":"J Hori","year":"2006","unstructured":"Hori J, Wang M, Kamiya K, Takahashi H, Sakuragawa N. Immunological characteristics of amniotic epithelium. Cornea. 2006;25:S53\u20138.","journal-title":"Cornea"},{"key":"3379_CR70","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1095\/biolreprod.106.055244","volume":"77","author":"S Ilancheran","year":"2007","unstructured":"Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod. 2007;77:577\u201388.","journal-title":"Biol Reprod"},{"key":"3379_CR71","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12015-006-0020-0","volume":"2","author":"T Miki","year":"2006","unstructured":"Miki T, Strom SC. Amnion-derived pluripotent\/multipotent stem cells. Stem Cell Rev. 2006;2:133\u201342.","journal-title":"Stem Cell Rev"},{"key":"3379_CR72","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.fertnstert.2007.06.106","volume":"90","author":"K Stefanidis","year":"2008","unstructured":"Stefanidis K, Loutradis D, Koumbi L, Anastasiadou V, Dinopoulou V, Kiapekou E, et al. Deleted in Azoospermia-Like (DAZL) gene-expressing cells in human amniotic fluid: a new source for germ cells research? Fertil Steril. 2008;90:798\u2013804.","journal-title":"Fertil Steril"},{"key":"3379_CR73","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.molmed.2013.01.001","volume":"19","author":"M Rosner","year":"2013","unstructured":"Rosner M, Hengstschl\u00e4ger M. Amniotic fluid stem cells and fetal cell microchimerism. Trends Mol Med. 2013;19:271\u20132.","journal-title":"Trends Mol Med"},{"key":"3379_CR74","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.it.2012.03.002","volume":"33","author":"JL Nelson","year":"2012","unstructured":"Nelson JL. The otherness of self: microchimerism in health and disease. Trends Immunol. 2012;33:421\u20137.","journal-title":"Trends Immunol"},{"key":"3379_CR75","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nri.2017.38","volume":"17","author":"JM Kinder","year":"2017","unstructured":"Kinder JM, Stelzer IA, Arck PC, Way SS. Immunological implications of pregnancy-induced microchimerism. Nat Rev Immunol. 2017;17:483\u201394.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3379_CR76","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.14488","volume":"1487","author":"S Vadakke-Madathil","year":"2020","unstructured":"Vadakke-Madathil S, Chaudry HW. Chimerism as the basis for organ repair. Ann N Y Acad Sci. 2020;1487(1):12\u201320.","journal-title":"Ann N Y Acad Sci."},{"key":"3379_CR77","volume-title":"Pathologisch-anatomische Untersuchungen \u00fcber Puerperal-Eklampsie","author":"CG Schmorl","year":"1893","unstructured":"Schmorl CG. Pathologisch-anatomische Untersuchungen \u00fcber Puerperal-Eklampsie. Leipzig: Verlag FCW Vogel; 1893."},{"key":"3379_CR78","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/clinchem\/hvaa304","volume":"67","author":"DW Bianchi","year":"2021","unstructured":"Bianchi DW, Khosrotehrani K, Way SS, MacKenzie TC, Bajema I, O\u2019Donoghue K. Forever connected: the lifelong biological consequences of fetomaternal and maternofetal microchimerism. Clin Chem. 2021;67:351\u201362.","journal-title":"Clin Chem"},{"key":"3379_CR79","doi-asserted-by":"publisher","first-page":"108399","DOI":"10.1016\/j.mrrev.2021.108399","volume":"788","author":"M Rosner","year":"2021","unstructured":"Rosner M, Kolbe T, Hengstschl\u00e4ger M. Fetomaternal microchimerism and genetic diagnosis: on the origins of fetal cells and cell-free fetal DNA in the pregnant woman. Mutat Res Rev Mutat Res. 2021;788:108399.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"3379_CR80","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.bpobgyn.2004.06.007","volume":"18","author":"DW Bianchi","year":"2004","unstructured":"Bianchi DW. Fetomaternal cell traffic, pregnancy-associated progenitor cells, and autoimmune disease. Best Pract Res Clin Obstet Gynaecol. 2004;18:959\u201375.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"3379_CR81","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s12015-019-09885-4","volume":"15","author":"CA Cismaru","year":"2019","unstructured":"Cismaru CA, Soritau O, Jurj AM, Lajos R, Pop B, Bocean C, et al. Isolation and characterization of a fetal-maternal microchimeric stem cell population in maternal hair follicles long after parturition. Stem Cell Rev Rep. 2019;15:519\u201329.","journal-title":"Stem Cell Rev Rep"},{"key":"3379_CR82","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41467-017-00661-x","volume":"8","author":"M Rosner","year":"2017","unstructured":"Rosner M, Pham HTT, Moriggl R, Hengstschl\u00e4ger M. Human stem cells alter the invasive properties of somatic cells via paracrine activation of mTORC1. Nat Commun. 2017;8:595.","journal-title":"Nat Commun"},{"key":"3379_CR83","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jpedsurg.2017.03.027","volume":"52","author":"CD Graham","year":"2017","unstructured":"Graham CD, Shieh HF, Brazzo JA 3rd, Zurakowski D, Fauza DO. Donor mesenchymal stem cells home to maternal wounds after transamniotic stem cell therapy (TRASCET) in a rodent model. J Pediatr Surg. 2017;52:1006\u20139.","journal-title":"J Pediatr Surg"},{"key":"3379_CR84","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/j.1365-2443.2009.01356.x","volume":"14","author":"S Nagata","year":"2009","unstructured":"Nagata S, Toyoda M, Yamaguchi S, Hirano K, Makino H, Nishino K, et al. Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells. Genes Cells. 2009;14:1395\u2013404.","journal-title":"Genes Cells"},{"key":"3379_CR85","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1089\/scd.2011.0435","volume":"21","author":"X Ge","year":"2012","unstructured":"Ge X, Wang IN, Toma I, Sebastiano V, Liu J, Butte MJ, et al. Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells. Stem Cells Dev. 2012;21:2798\u2013808.","journal-title":"Stem Cells Dev"},{"key":"3379_CR86","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nprot.2013.011","volume":"8","author":"M Rosner","year":"2013","unstructured":"Rosner M, Schipany K, Hengstschl\u00e4ger M. Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle. Nat Protoc. 2013;8:602\u201326.","journal-title":"Nat Protoc"},{"key":"3379_CR87","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1089\/ten.tec.2013.0480","volume":"20","author":"G Jiang","year":"2014","unstructured":"Jiang G, Di Bernardo J, DeLong CJ, Monteiro da Rocha A, O\u2019shea KS, Kunisaki SM. Induced pluripotent stem cells from human placental chorion for perinatal tissue engineering applications. Tissue Eng Part C Methods. 2014;20:731\u201340.","journal-title":"Tissue Eng Part C Methods"},{"key":"3379_CR88","doi-asserted-by":"publisher","first-page":"558","DOI":"10.7150\/ijbs.11051","volume":"12","author":"M Qin","year":"2016","unstructured":"Qin M, Chen R, Li H, Liang H, Xue Q, Li F, et al. Direct reprogramming of human amniotic fluid stem cells by OCT4 and application in repairing of cerebral ischemia damage. Int J Biol Sci. 2016;12:558\u201368.","journal-title":"Int J Biol Sci"},{"key":"3379_CR89","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/7651_2014_163","volume":"1357","author":"C Miere","year":"2016","unstructured":"Miere C, Devito L, Ilic D. Sendai virus-based reprogramming of mesenchymal stromal\/stem cells from umbilical cord Wharton\u2019s Jelly into induced pluripotent stem cells. Methods Mol Biol. 2016;1357:33\u201344.","journal-title":"Methods Mol Biol"},{"key":"3379_CR90","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/jcb.25733","volume":"118","author":"CY Fong","year":"2017","unstructured":"Fong CY, Biswas A, Stunkel W, Chong YS, Bongso A. Tissues derived from reprogrammed Wharton\u2019s Jelly stem cells of the umbilical cord provide an ideal platform to study the effects of glucose, Zika virus, and other agents on the fetus. J Cell Biochem. 2017;118:437\u201341.","journal-title":"J Cell Biochem"},{"key":"3379_CR91","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.canlet.2018.04.026","volume":"428","author":"X Zhao","year":"2018","unstructured":"Zhao X, Wu X, Qian M, Song Y, Wu D, Zhang W. Knockdown of TGF-\u03b21 expression in human umbilical cord mesenchymal stem cells reverts their exosome-mediated EMT promoting effect on lung cancer cells. Cancer Lett. 2018;428:34\u201344.","journal-title":"Cancer Lett"},{"key":"3379_CR92","doi-asserted-by":"publisher","first-page":"102345","DOI":"10.1016\/j.scr.2021.102345","volume":"53","author":"TTT Tran","year":"2021","unstructured":"Tran TTT, Nguyen THN, Nguyen TT, Nguyen XH. Establishment of a Vietnamese ethnicity induced pluripotent stem cell line (VRISGi001-A) from umbilical cord blood hematopoietic stem cells under a feeder-free system. Stem Cell Res. 2021;53:102345.","journal-title":"Stem Cell Res"},{"key":"3379_CR93","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1089\/scd.2010.0424","volume":"20","author":"S Bollini","year":"2011","unstructured":"Bollini S, Cheung KK, Riegler J, Dong X, Smart N, Ghionzoli M, et al. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev. 2011;20:1985\u201394.","journal-title":"Stem Cells Dev"},{"key":"3379_CR94","doi-asserted-by":"publisher","first-page":"e26535","DOI":"10.1371\/journal.pone.0026535","volume":"6","author":"EC Moorefield","year":"2011","unstructured":"Moorefield EC, McKee EE, Solchaga L, Orlando G, Yoo JJ, Walker S, et al. Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response. PLoS One. 2011;6:e26535.","journal-title":"PLoS One"},{"key":"3379_CR95","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1089\/scd.2012.0267","volume":"22","author":"D Moschidou","year":"2013","unstructured":"Moschidou D, Mukherjee S, Blundell MP, Jones GN, Atala AJ, Thrasher AJ, et al. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics. Stem Cells Dev. 2013;22:444\u201358.","journal-title":"Stem Cells Dev"},{"key":"3379_CR96","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13287-017-0582-6","volume":"8","author":"R Moraghebi","year":"2017","unstructured":"Moraghebi R, Kirkeby A, Chaves P, R\u00f6nn RE, Sitnicka E, Parmar M, et al. Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications. Stem Cell Res Ther. 2017;8:190.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR97","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1038\/s41598-018-23396-1","volume":"8","author":"M Wu","year":"2018","unstructured":"Wu M, Zhang R, Zou Q, Chen Y, Zhou M, Li X, et al. Comparison of the biological characteristics of mesenchymal stem cells derived from the human placenta and umbilical cord. Sci Rep. 2018;8:5014.","journal-title":"Sci Rep"},{"key":"3379_CR98","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1432-0436.2006.00139.x","volume":"75","author":"VL Battula","year":"2007","unstructured":"Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, Hojak S, et al. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation. 2007;75:279\u201391.","journal-title":"Differentiation"},{"key":"3379_CR99","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/term.40","volume":"1","author":"M Soncini","year":"2007","unstructured":"Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med. 2007;1:296\u2013305.","journal-title":"J Tissue Eng Regen Med"},{"key":"3379_CR100","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.diff.2012.05.007","volume":"84","author":"HJ Lee","year":"2012","unstructured":"Lee HJ, Jung J, Cho KJ, Lee CK, Hwang SG, Kim GJ. Comparison of in vitro hepatogenic differentiation potential between various placenta-derived stem cells and other adult stem cells as an alternative source of functional hepatocytes. Differentiation. 2012;84:223\u201331.","journal-title":"Differentiation"},{"key":"3379_CR101","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1634\/stemcells.2007-0439","volume":"26","author":"DL Troyer","year":"2008","unstructured":"Troyer DL, Weiss ML. Wharton\u2019s jelly-derived cells are a primitive stromal cell population. Stem Cells. 2008;26:591\u20139.","journal-title":"Stem Cells"},{"key":"3379_CR102","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1574888X11308020005","volume":"8","author":"AK Batsali","year":"2013","unstructured":"Batsali AK, Kastrinaki MC, Papadaki HA, Pontikoglou C. Mesenchymal stem cells derived from Wharton\u2019s Jelly of the umbilical cord: biological properties and emerging clinical applications. Curr Stem Cell Res Ther. 2013;8:144\u201355.","journal-title":"Curr Stem Cell Res Ther"},{"key":"3379_CR103","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1177\/1933719113488443","volume":"20","author":"M Messerli","year":"2013","unstructured":"Messerli M, Wagner A, Sager R, Mueller M, Baumann M, Surbek DV, et al. Stem cells from umbilical cord Wharton\u2019s jelly from preterm birth have neuroglial differentiation potential. Reprod Sci. 2013;20:1455\u201364.","journal-title":"Reprod Sci"},{"key":"3379_CR104","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/14653240410005041","volume":"6","author":"SE Yang","year":"2004","unstructured":"Yang SE, Ha CW, Jung M, Jin HJ, Lee M, Song H, et al. Mesenchymal stem\/progenitor cells developed in cultures from UC blood. Cytotherapy. 2004;6:476\u201386.","journal-title":"Cytotherapy"},{"key":"3379_CR105","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13287-016-0465-2","volume":"8","author":"E Amati","year":"2017","unstructured":"Amati E, Sella S, Perbellini O, Alghisi A, Bernardi M, Chieregato K, et al. Generation of mesenchymal stromal cells from cord blood: evaluation of in vitro quality parameters prior to clinical use. Stem Cell Res Ther. 2017;8:14.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR106","doi-asserted-by":"publisher","first-page":"5180579","DOI":"10.1155\/2017\/5180579","volume":"2017","author":"YB Lee","year":"2017","unstructured":"Lee YB, Choi JH, Kim EN, Seok J, Lee HJ, Yoon JH, et al. Human chorionic plate-derived mesenchymal stem cells restore hepatic lipid metabolism in a rat model of bile duct ligation. Stem Cells Int. 2017;2017:5180579.","journal-title":"Stem Cells Int"},{"key":"3379_CR107","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4252\/wjsc.v7.i1.195","volume":"7","author":"L Lankford","year":"2015","unstructured":"Lankford L, Selby T, Becker J, Ryzhuk V, Long C, Farmer D, et al. Early gestation chorionic villi-derived stromal cells for fetal tissue engineering. World J Stem Cells. 2015;7:195\u2013207.","journal-title":"World J Stem Cells"},{"key":"3379_CR108","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13287-021-02295-9","volume":"12","author":"R Zhankina","year":"2021","unstructured":"Zhankina R, Baghban N, Askarov M, Saipiyeva D, Ibragimov A, Kadirova B, Zhanbyrbekuly U, et al. Mesenchymal stromal\/stem cells and their exosomes for restoration of spermatogenesis in non-obstructive azoospermia: a systemic review. Stem Cell Res Ther. 2021;12:229.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR109","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/humupd\/dmv001","volume":"21","author":"S Hendriks","year":"2015","unstructured":"Hendriks S, Dancet EA, van Pelt AM, Hamer G, Repping S. Artificial gametes: a systematic review of biological progress towards clinical application. Hum Reprod Update. 2015;21:285\u201396.","journal-title":"Hum Reprod Update"},{"key":"3379_CR110","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3389\/fbioe.2020.00781","volume":"8","author":"PY Zhang","year":"2020","unstructured":"Zhang PY, Fan Y, Tan T, Yu Y. Generation of artificial gamete and embryo from stem cells in reproductive medicine. Front Bioeng Biotechnol. 2020;8:781.","journal-title":"Front Bioeng Biotechnol"},{"key":"3379_CR111","doi-asserted-by":"publisher","first-page":"eaaz6830","DOI":"10.1126\/science.aaz6830","volume":"374","author":"M Saitou","year":"2021","unstructured":"Saitou M, Hayashi K. Mammalian in vitro gametogenesis. Science. 2021;374:eaaz6830.","journal-title":"Science"},{"key":"3379_CR112","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s43032-021-00566-7","volume":"28","author":"P Petric","year":"2021","unstructured":"Petric P, Vrtacnik-Bokal E, Stimpfel M. Is it possible to treat infertility with stem cells? Reprod Sci. 2021;28:1733\u201345.","journal-title":"Reprod Sci"},{"key":"3379_CR113","doi-asserted-by":"publisher","first-page":"102468","DOI":"10.1016\/j.dsx.2022.102468","volume":"16","author":"RM Al Haj Ahmad","year":"2022","unstructured":"Al Haj Ahmad RM, Ababneh NA, Al-Domi HA. Brain insulin resistance as a mechanistic mediator links peripheral metabolic disorders with declining cognition. Diabetes Metab Syndr. 2022;16:102468.","journal-title":"Diabetes Metab Syndr"},{"key":"3379_CR114","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.scr.2017.12.008","volume":"27","author":"S Parveen","year":"2018","unstructured":"Parveen S. Establishment and characterization of induced pluripotent stem cells from placental mesenchymal stromal cells. Stem Cell Res. 2018;27:15\u201320.","journal-title":"Stem Cell Res"},{"key":"3379_CR115","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.scr.2017.02.013","volume":"20","author":"A Tangprasittipap","year":"2017","unstructured":"Tangprasittipap A, Jittorntrum B, Wongkummool W, Kitiyanant N, Tubsuwan A. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman. Stem Cell Res. 2017;20:91\u20133.","journal-title":"Stem Cell Res"},{"key":"3379_CR116","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.tjog.2017.10.012","volume":"56","author":"SWS Shaw","year":"2017","unstructured":"Shaw SWS, Cheng PJ, Chang YL, Chao AS, Wang TH, Chang SD, et al. Human amniotic fluid stem cells have better potential in early second trimester of pregnancy and can be reprogramed to iPS. Taiwan J Obstet Gynecol. 2017;56:770\u20134.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"3379_CR117","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ymthe.2016.11.014","volume":"25","author":"KE Hawkins","year":"2017","unstructured":"Hawkins KE, Moschidou D, Faccenda D, Wruck W, Martin-Trujillo A, Hau KL, et al. Human amniocytes are receptive to chemically induced reprogramming to pluripotency. Mol Ther. 2017;25:427\u201342.","journal-title":"Mol Ther"},{"key":"3379_CR118","doi-asserted-by":"publisher","first-page":"a023473","DOI":"10.1101\/cshperspect.a023473","volume":"5","author":"T Hod","year":"2015","unstructured":"Hod T, Cerdeira AS, Karumanchi SA. Molecular mechanisms of preeclampsia. Cold Spring Harb Perspect Med. 2015;5:a023473.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3379_CR119","doi-asserted-by":"publisher","first-page":"1507674","DOI":"10.1155\/2018\/1507674","volume":"2018","author":"HC Bartels","year":"2018","unstructured":"Bartels HC, Postle JD, Downey P, Brennan DJ. Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers. Dis Markers. 2018;2018:1507674.","journal-title":"Dis Markers"},{"key":"3379_CR120","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/clinchem\/hvac056","volume":"68","author":"M Rosner","year":"2022","unstructured":"Rosner M, Hengstschl\u00e4ger M. Fetomaternal microchimerism and amniotic fluid stem cells: the current state of knowledge. Clin Chem. 2022;68:761\u20134.","journal-title":"Clin Chem"},{"key":"3379_CR121","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","volume":"350","author":"YM Lo","year":"1997","unstructured":"Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485\u20137.","journal-title":"Lancet"},{"key":"3379_CR122","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/cge.12598","volume":"89","author":"P Brady","year":"2016","unstructured":"Brady P, Brison N, Van Den Bogaert K, de Ravel T, Peeters H, Van Esch H, et al. Clinical implementation of NIPT - technical and biological challenges. Clin Genet. 2016;89:523\u201330.","journal-title":"Clin Genet"},{"key":"3379_CR123","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1056\/NEJMra1705345","volume":"379","author":"DW Bianchi","year":"2018","unstructured":"Bianchi DW, Chiu RWK. Sequencing of circulating cell-free DNA during pregnancy. N Engl J Med. 2018;379:464\u201373.","journal-title":"N Engl J Med"},{"key":"3379_CR124","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/stcltm\/szab003","volume":"11","author":"M Rosner","year":"2022","unstructured":"Rosner M, Hengstschl\u00e4ger M. Stem cell-induced cell motility: a removable obstacle on the way to safe therapies? Stem Cells Transl Med. 2022;11:26\u201334.","journal-title":"Stem Cells Transl Med"},{"key":"3379_CR125","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/sctm.20-0268","volume":"10","author":"V Castelli","year":"2021","unstructured":"Castelli V, Antonucci I, d\u2019Angelo M, Tessitore A, Zelli V, Benedetti E, et al. Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia\/reperfusion model. Stem Cells Transl Med. 2021;10:251\u201366.","journal-title":"Stem Cells Transl Med"},{"key":"3379_CR126","doi-asserted-by":"publisher","first-page":"348","DOI":"10.21037\/cdt-20-1032","volume":"11","author":"J Hu","year":"2021","unstructured":"Hu J, Chen X, Li P, Lu X, Yan J, Tan H, et al. Exosomes derived from human amniotic fluid mesenchymal stem cells alleviate cardiac fibrosis via enhancing angiogenesis in vivo and in vitro. Cardiovasc Diagn Ther. 2021;11:348\u201361.","journal-title":"Cardiovasc Diagn Ther"},{"key":"3379_CR127","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3892\/or.2015.4109","volume":"34","author":"T Li","year":"2015","unstructured":"Li T, Zhang C, Ding Y, Zhai W, Liu K, Bu F, et al. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway. Oncol Rep. 2015;34:1469\u201377.","journal-title":"Oncol Rep"},{"key":"3379_CR128","doi-asserted-by":"publisher","first-page":"9156731","DOI":"10.1155\/2016\/9156731","volume":"2016","author":"Y Huang","year":"2016","unstructured":"Huang Y, Wu Y, Chang X, Li Y, Wang K, Duan T. Effects of human umbilical cord mesenchymal stem cells on human trophoblast cell functions in vitro. Stem Cells Int. 2016;2016:9156731.","journal-title":"Stem Cells Int"},{"key":"3379_CR129","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/s12885-016-2595-4","volume":"16","author":"C Liu","year":"2016","unstructured":"Liu C, Liu Y, Xu XX, Guo X, Sun GW, Ma XJ. Mesenchymal stem cells enhance the metastasis of 3D-cultured hepatocellular carcinoma cells. BMC Cancer. 2016;16:566.","journal-title":"BMC Cancer"},{"key":"3379_CR130","first-page":"1843","volume":"54","author":"X Zhou","year":"2019","unstructured":"Zhou X, Li T, Chen Y, Zhang N, Wang P, Liang Y, et al. Mesenchymal stem cell-derived extracellular vesicles promote the in vitro proliferation and migration of breast cancer cells through the activation of the ERK pathway. Int J Oncol. 2019;54:1843\u201352.","journal-title":"Int J Oncol"},{"key":"3379_CR131","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1093\/carcin\/bgu192","volume":"35","author":"C Zhang","year":"2014","unstructured":"Zhang C, Zhou C, Wu XJ, Yang M, Yang ZH, Xiong HZ, et al. Human CD133-positive hematopoietic progenitor cells initiate growth and metastasis of colorectal cancer cells. Carcinogenesis. 2014;35:2771\u20137.","journal-title":"Carcinogenesis"},{"key":"3379_CR132","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00432-018-2802-6","volume":"145","author":"D Meng","year":"2019","unstructured":"Meng D, Meng M, Luo A, Jing X, Wang G, Huang S, et al. Effects of VEGFR1+ hematopoietic progenitor cells on pre-metastatic niche formation and in vivo metastasis of breast cancer cells. J Cancer Res Clin Oncol. 2019;145:411\u201327.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3379_CR133","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.placenta.2013.06.311","volume":"34","author":"CP Chen","year":"2013","unstructured":"Chen CP, Huang JP, Chu TY, Aplin JD, Chen CY, Wu YH. Human placental multipotent mesenchymal stromal cells modulate trophoblast migration via Rap1 activation. Placenta. 2013;34:913\u201323.","journal-title":"Placenta"},{"key":"3379_CR134","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1089\/scd.2012.0674","volume":"23","author":"JH Choi","year":"2014","unstructured":"Choi JH, Jung J, Na KH, Cho KJ, Yoon TK, Kim GJ. Effect of mesenchymal stem cells and extracts derived from the placenta on trophoblast invasion and immune responses. Stem Cells Dev. 2014;23:132\u201345.","journal-title":"Stem Cells Dev"},{"key":"3379_CR135","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejcb.2016.02.001","volume":"95","author":"W Kamprom","year":"2016","unstructured":"Kamprom W, Kheolamai P, U-Pratya Y, Supokawej A, Wattanapanitch M, Laowtammathron C, et al. Effects of mesenchymal stem cell-derived cytokines on the functional properties of endothelial progenitor cells. Eur J Cell Biol. 2016;95:153\u201363.","journal-title":"Eur J Cell Biol"},{"key":"3379_CR136","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1089\/ten.teb.2013.0664","volume":"20","author":"R El Omar","year":"2014","unstructured":"El Omar R, Beroud J, Stoltz JF, Menu P, Velot E, Decot V. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? Tissue Eng Part B Rev. 2014;20:523\u201344.","journal-title":"Tissue Eng Part B Rev"},{"key":"3379_CR137","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","volume":"108","author":"F Zegers-Hochschild","year":"2017","unstructured":"Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The international glossary on infertility and fertility care, 2017. Fertil Steril. 2017;108:393\u2013406.","journal-title":"Fertil Steril"},{"key":"3379_CR138","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clinbiochem.2018.03.012","volume":"62","author":"M Vander Borght","year":"2018","unstructured":"Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2\u201310.","journal-title":"Clin Biochem"},{"key":"3379_CR139","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12016-016-8586-z","volume":"53","author":"A Deroux","year":"2017","unstructured":"Deroux A, Dumestre-Perard C, Dunand-Faure C, Bouillet L, Hoffmann P. Female infertility and serum auto-antibodies: a systematic review. Clin Rev Allergy Immunol. 2017;53:78\u201386.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3379_CR140","doi-asserted-by":"publisher","first-page":"e28218","DOI":"10.4161\/spmg.28218","volume":"4","author":"M Wosnitzer","year":"2014","unstructured":"Wosnitzer M, Goldstein M, Hardy MP. Review of azoospermia. Spermatogenesis. 2014;4:e28218.","journal-title":"Spermatogenesis"},{"key":"3379_CR141","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.fertnstert.2018.09.012","volume":"110","author":"Practice committee of the American Society for Reproductive Medicine","year":"2018","unstructured":"Practice committee of the American Society for Reproductive Medicine. Management of nonobstructive azoospermia: a committee opinion. Fertil Steril. 2018;110:1239\u201345.","journal-title":"Fertil Steril"},{"key":"3379_CR142","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/humupd\/dmaa006","volume":"26","author":"SC Esteves","year":"2020","unstructured":"Esteves SC, Ramasamy R, Colpi GM, Carvalho JF, Schlegel PN. Sperm retrieval rates by micro-TESE versus conventional TESE in men with non-obstructive azoospermia-the assumption of independence in effect sizes might lead to misleading conclusions. Hum Reprod Update. 2020;26:603\u20135.","journal-title":"Hum Reprod Update"},{"key":"3379_CR143","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/14656566.2018.1543405","volume":"20","author":"Y Duca","year":"2019","unstructured":"Duca Y, Calogero AE, Cannarella R, Condorelli RA, La Vignera S. Current and emerging medical therapeutic agents for idiopathic male infertility. Expert Opin Pharmacother. 2019;20:55\u201367.","journal-title":"Expert Opin Pharmacother"},{"key":"3379_CR144","doi-asserted-by":"publisher","first-page":"R139","DOI":"10.1530\/REP-14-0431","volume":"149","author":"G Manku","year":"2015","unstructured":"Manku G, Culty M. Mammalian gonocyte and spermatogonia differentiation: recent advances and remaining challenges. Reproduction. 2015;149:R139\u201357.","journal-title":"Reproduction"},{"key":"3379_CR145","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1146\/annurev-genet-120215-035449","volume":"51","author":"C Spiller","year":"2017","unstructured":"Spiller C, Koopman P, Bowles J. Sex determination in the mammalian germline. Annu Rev Genet. 2017;51:265\u201385.","journal-title":"Annu Rev Genet"},{"key":"3379_CR146","doi-asserted-by":"publisher","first-page":"e101033","DOI":"10.15252\/embj.2018101033","volume":"38","author":"S Bar","year":"2019","unstructured":"Bar S, Benvenisty N. Epigenetic aberrations in human pluripotent stem cells. EMBO J. 2019;38:e101033.","journal-title":"EMBO J"},{"key":"3379_CR147","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371:2488\u201398.","journal-title":"N Engl J Med"},{"key":"3379_CR148","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41586-018-0811-x","volume":"565","author":"A Yokoyama","year":"2019","unstructured":"Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature. 2019;565:312\u20137.","journal-title":"Nature"},{"key":"3379_CR149","doi-asserted-by":"publisher","first-page":"15183","DOI":"10.1038\/ncomms15183","volume":"8","author":"B Milholland","year":"2017","unstructured":"Milholland B, Dong X, Zhang L, Hao X, Suh Y, Vijg J. Differences between germline and somatic mutation rates in humans and mice. Nat Commun. 2017;8:15183.","journal-title":"Nat Commun"},{"key":"3379_CR150","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1226889","volume":"338","author":"K Hayashi","year":"2012","unstructured":"Hayashi K, Ogushi S, Kurimoto K, Shimamoto S, Ohta H, Saitou M. Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice. Science. 2012;338:971\u20135.","journal-title":"Science"},{"key":"3379_CR151","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nature20104","volume":"539","author":"O Hikabe","year":"2016","unstructured":"Hikabe O, Hamazaki N, Nagamatsu G, Obata Y, Hirao Y, Hamada N, et al. Reconstitution in vitro of the entire cycle of the mouse female germ line. Nature. 2016;539:299\u2013303.","journal-title":"Nature"},{"key":"3379_CR152","doi-asserted-by":"publisher","first-page":"eaaw5754","DOI":"10.1126\/science.aaw5754","volume":"366","author":"Y Niu","year":"2019","unstructured":"Niu Y, Sun N, Li C, Lei Y, Huang Z, Wu J, et al. Dissecting primate early post-implantation development using long-term in vitro embryo culture. Science. 2019;366:eaaw5754.","journal-title":"Science"},{"key":"3379_CR153","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1016\/j.celrep.2019.11.083","volume":"29","author":"D Chen","year":"2019","unstructured":"Chen D, Sun N, Hou L, Kim R, Faith J, Aslanyan M, et al. Human primordial germ cells are specified from lineage-primed progenitors. Cell Rep. 2019;29:4568\u201382.","journal-title":"Cell Rep"},{"key":"3379_CR154","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1089\/dna.2011.1396","volume":"31","author":"X Cheng","year":"2012","unstructured":"Cheng X, Chen S, Yu X, Zheng P, Wang H. BMP15 gene is activated during human amniotic fluid stem cell differentiation into oocyte-like cells. DNA Cell Biol. 2012;31:1198\u2013204.","journal-title":"DNA Cell Biol"},{"key":"3379_CR155","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1477-7827-10-108","volume":"10","author":"A Evron","year":"2012","unstructured":"Evron A, Goldman S, Shalev E. Human amniotic epithelial cells differentiate into cells expressing germ cell specific markers when cultured in medium containing serum substitute supplement. Reprod Biol Endocrinol. 2012;10:108.","journal-title":"Reprod Biol Endocrinol"},{"key":"3379_CR156","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1095\/biolreprod.113.112920","volume":"90","author":"X Yu","year":"2014","unstructured":"Yu X, Wang N, Qiang R, Wan Q, Qin M, Chen S, et al. Human amniotic fluid stem cells possess the potential to differentiate into primordial follicle oocytes in vitro. Biol Reprod. 2014;90:73.","journal-title":"Biol Reprod"},{"key":"3379_CR157","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s11626-016-0073-6","volume":"52","author":"Z Afsartala","year":"2016","unstructured":"Afsartala Z, Rezvanfar MA, Hodjat M, Tanha S, Assadollahi V, Bijangi K, et al. Amniotic membrane mesenchymal stem cells can differentiate into germ cells in vitro. In Vitro Cell Dev Biol Anim. 2016;52:1060\u201371.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"3379_CR158","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1089\/cell.2016.0035","volume":"19","author":"HR Asgari","year":"2017","unstructured":"Asgari HR, Akbari M, Yazdekhasti H, Rajabi Z, Navid S, Aliakbari F, et al. Comparison of human amniotic, chorionic, and umbilical cord multipotent mesenchymal stem cells regarding their capacity for differentiation toward female germ cells. Cell Reprogram. 2017;19:44\u201353.","journal-title":"Cell Reprogram"},{"key":"3379_CR159","first-page":"59","volume":"21","author":"F Alifi","year":"2020","unstructured":"Alifi F, Asgari HR. Alteration in expression of primordial germ cell (PGC) markers during induction of human amniotic mesenchymal stem cells (hAMSCs). J Reprod Infertil. 2020;21:59\u201364.","journal-title":"J Reprod Infertil"},{"key":"3379_CR160","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13287-017-0491-8","volume":"8","author":"E Shlush","year":"2017","unstructured":"Shlush E, Maghen L, Swanson S, Kenigsberg S, Moskovtsev S, Barretto T, et al. In vitro generation of Sertoli-like and haploid spermatid-like cells from human umbilical cord perivascular cells. Stem Cell Res Ther. 2017;8:37.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR161","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3892\/mmr.2015.3528","volume":"12","author":"H Chen","year":"2015","unstructured":"Chen H, Tang QL, Wu XY, Xie LC, Lin LM, Ho GY, et al. Differentiation of human umbilical cord mesenchymal stem cells into germ-like cells in mouse seminiferous tubules. Mol Med Rep. 2015;12:819\u201328.","journal-title":"Mol Med Rep"},{"key":"3379_CR162","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13287-017-0514-5","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Mao Q, He J, She H, Zhang Z, Yin C. Human umbilical cord mesenchymal stem cells improve the reserve function of perimenopausal ovary via a paracrine mechanism. Stem Cell Res Ther. 2017;8:55.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR163","doi-asserted-by":"publisher","first-page":"6539294","DOI":"10.1155\/2019\/6539294","volume":"2019","author":"Q Zheng","year":"2019","unstructured":"Zheng Q, Fu X, Jiang J, Zhang N, Zou L, Wang W, et al. Umbilical cord mesenchymal stem cell transplantation prevents chemotherapy-induced ovarian failure via the NGF\/TrkA pathway in rats. Biomed Res Int. 2019;2019:6539294.","journal-title":"Biomed Res Int"},{"key":"3379_CR164","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4252\/wjsc.v12.i4.277","volume":"12","author":"J Shen","year":"2020","unstructured":"Shen J, Cao D, Sun JL. Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure. World J Stem Cells. 2020;12:277\u201387.","journal-title":"World J Stem Cells"},{"key":"3379_CR165","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1007\/s43032-020-00147-0","volume":"27","author":"X Feng","year":"2020","unstructured":"Feng X, Ling L, Zhang W, Liu X, Wang Y, Luo Y, et al. Effects of human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation in situ on primary ovarian insufficiency in SD rats. Reprod Sci. 2020;27:1502\u201312.","journal-title":"Reprod Sci"},{"key":"3379_CR166","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13287-019-1315-9","volume":"10","author":"R Liu","year":"2019","unstructured":"Liu R, Zhang X, Fan Z, Wang Y, Yao G, Wan X, et al. Human amniotic mesenchymal stem cells improve the follicular microenvironment to recover ovarian function in premature ovarian failure mice. Stem Cell Res Ther. 2019;10:299.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR167","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s13287-020-02002-0","volume":"11","author":"JH Choi","year":"2020","unstructured":"Choi JH, Seok J, Lim SM, Kim TH, Kim GJ. Microenvironmental changes induced by placenta-derived mesenchymal stem cells restore ovarian function in ovariectomized rats via activation of the PI3K-FOXO3 pathway. Stem Cell Res Ther. 2020;11:486.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR168","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s13287-020-01904-3","volume":"11","author":"L Cui","year":"2020","unstructured":"Cui L, Bao H, Liu Z, Man X, Liu H, Hou Y, et al. hUMSCs regulate the differentiation of ovarian stromal cells via TGF-\u03b2 1\/Smad3 signaling pathway to inhibit ovarian fibrosis to repair ovarian function in POI rats. Stem Cell Res Ther. 2020;11:386.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR169","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s13287-020-01988-x","volume":"11","author":"KH Kim","year":"2020","unstructured":"Kim KH, Kim EY, Kim GJ, Ko JJ, Cha KY, Koong MK, et al. Human placenta-derived mesenchymal stem cells stimulate ovarian function via miR-145 and bone morphogenetic protein signaling in aged rats. Stem Cell Res Ther. 2020;11:472.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR170","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.18632\/aging.102794","volume":"12","author":"C Ding","year":"2020","unstructured":"Ding C, Zou Q, Wu Y, Lu J, Qian C, Li H, et al. EGF released from human placental mesenchymal stem cells improves premature ovarian insufficiency via NRF2\/HO-1 activation. Aging (Albany NY). 2020;12:2992\u20133009.","journal-title":"Aging (Albany NY)"},{"key":"3379_CR171","doi-asserted-by":"publisher","first-page":"3695848","DOI":"10.1155\/2022\/3695848","volume":"2022","author":"Z Geng","year":"2022","unstructured":"Geng Z, Chen H, Zou G, Yuan L, Liu P, Li B, et al. Human amniotic fluid mesenchymal stem cell-derived exosomes inhibit apoptosis in ovarian granulosa cell via miR-369-3p\/YAF2\/PDCD5\/p53 pathway. Oxid Med Cell Longev. 2022;2022:3695848.","journal-title":"Oxid Med Cell Longev"},{"key":"3379_CR172","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13287-018-0781-9","volume":"9","author":"C Ding","year":"2018","unstructured":"Ding C, Zou Q, Wang F, Wu H, Chen R, Lv J, et al. Human amniotic mesenchymal stem cells improve ovarian function in natural aging through secreting hepatocyte growth factor and epidermal growth factor. Stem Cell Res Ther. 2018;9:55.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR173","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41374-020-00513-1","volume":"101","author":"J Cho","year":"2021","unstructured":"Cho J, Kim TH, Seok J, Jun JH, Park H, Kweon M, et al. Vascular remodeling by placenta-derived mesenchymal stem cells restores ovarian function in ovariectomized rat model via the VEGF pathway. Lab Invest. 2021;101:304\u201317.","journal-title":"Lab Invest"},{"key":"3379_CR174","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s13287-017-0714-z","volume":"8","author":"Z Li","year":"2017","unstructured":"Li Z, Zhang Z, Ming WK, Chen X, Xiao XM. Tracing GFP-labeled WJMSCs in vivo using a chronic salpingitis model: an animal experiment. Stem Cell Res Ther. 2017;8:272.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR175","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.4238\/2015.April.17.10","volume":"14","author":"HJ Luo","year":"2015","unstructured":"Luo HJ, Xiao XM, Zhou J, Wei W. Therapeutic influence of intraperitoneal injection of Wharton\u2019s jelly-derived mesenchymal stem cells on oviduct function and fertility in rats with acute and chronic salpingitis. Genet Mol Res. 2015;14:3606\u201317.","journal-title":"Genet Mol Res"},{"key":"3379_CR176","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00404-019-05209-6","volume":"300","author":"W Liao","year":"2019","unstructured":"Liao W, Tang X, Li X, Li T. Therapeutic effect of human umbilical cord mesenchymal stem cells on tubal factor infertility using a chronic salpingitis murine model. Arch Gynecol Obstet. 2019;300:421\u20139.","journal-title":"Arch Gynecol Obstet"},{"key":"3379_CR177","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.fertnstert.2008.02.096","volume":"89","author":"D Yu","year":"2008","unstructured":"Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome-one century later. Fertil Steril. 2008;89:759\u201379.","journal-title":"Fertil Steril"},{"key":"3379_CR178","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13287-021-02682-2","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang J, Zhang W, Yu J, Gou Y, Liu N, Wang T, et al. Human amniotic mesenchymal stem cells combined with PPCNg facilitate injured endometrial regeneration. Stem Cell Res Ther. 2022;13:17.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR179","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13287-018-0904-3","volume":"9","author":"Y Cao","year":"2018","unstructured":"Cao Y, Sun H, Zhu H, Zhu X, Tang X, Yan G, et al. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial. Stem Cell Res Ther. 2018;9:192.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR180","doi-asserted-by":"publisher","first-page":"814543","DOI":"10.1155\/2015\/814543","volume":"2015","author":"RD Pereira","year":"2015","unstructured":"Pereira RD, De Long NE, Wang RC, Yazdi FT, Holloway AC, Raha S. Angiogenesis in the placenta: the role of reactive oxygen species signaling. Biomed Res Int. 2015;2015:814543.","journal-title":"Biomed Res Int"},{"key":"3379_CR181","doi-asserted-by":"publisher","first-page":"e0218437","DOI":"10.1371\/journal.pone.0218437","volume":"14","author":"D Surico","year":"2019","unstructured":"Surico D, Bordino V, Cantaluppi V, Mary D, Gentilli S, Oldani A, et al. Preeclampsia and intrauterine growth restriction: role of human umbilical cord mesenchymal stem cells-trophoblast cross-talk. PLoS One. 2019;14:e0218437.","journal-title":"PLoS One"},{"key":"3379_CR182","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1177\/1933719116630417","volume":"23","author":"LL Wang","year":"2016","unstructured":"Wang LL, Yu Y, Guan HB, Qiao C. Effect of human umbilical cord mesenchymal stem cell transplantation in a rat model of preeclampsia. Reprod Sci. 2016;23:1058\u201370.","journal-title":"Reprod Sci"},{"key":"3379_CR183","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1016\/j.biomaterials.2011.01.071","volume":"32","author":"T Mirabella","year":"2011","unstructured":"Mirabella T, Cilli M, Carlone S, Cancedda R, Gentili C. Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model. Biomaterials. 2011;32:3689\u201399.","journal-title":"Biomaterials"},{"key":"3379_CR184","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/sctm.16-0297","volume":"6","author":"C Balbi","year":"2017","unstructured":"Balbi C, Piccoli M, Barile L, Papait A, Armirotti A, Principi E, et al. First characterization of human amniotic fluid stem cell extracellular vesicles as a powerful paracrine tool endowed with regenerative potential. Stem Cells Transl Med. 2017;6:1340\u201355.","journal-title":"Stem Cells Transl Med"},{"key":"3379_CR185","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1089\/scd.2009.0138","volume":"19","author":"BS Yoon","year":"2010","unstructured":"Yoon BS, Moon JH, Jun EK, Kim J, Maeng I, Kim JS, et al. Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells. Stem Cells Dev. 2010;19:887\u2013902.","journal-title":"Stem Cells Dev"},{"key":"3379_CR186","doi-asserted-by":"publisher","first-page":"S320","DOI":"10.1016\/j.placenta.2011.04.010","volume":"32","author":"U Manuelpillai","year":"2011","unstructured":"Manuelpillai U, Moodley Y, Borlongan CV, Parolini O. Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta. 2011;32:S320\u20135.","journal-title":"Placenta"},{"key":"3379_CR187","first-page":"e18","volume":"8","author":"DL Steed","year":"2008","unstructured":"Steed DL, Trumpower C, Duffy D, Smith C, Marshall V, Rupp R, et al. Amnion-derived cellular cytokine solution: a physiological combination of cytokines for wound healing. Eplasty. 2008;8:e18.","journal-title":"Eplasty"},{"key":"3379_CR188","doi-asserted-by":"publisher","first-page":"e46956","DOI":"10.1371\/journal.pone.0046956","volume":"7","author":"D Rossi","year":"2012","unstructured":"Rossi D, Pianta S, Magatti M, Sedlmayr P, Parolini O. Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity. PLoS One. 2012;7:e46956.","journal-title":"PLoS One"},{"key":"3379_CR189","doi-asserted-by":"publisher","first-page":"e88319","DOI":"10.1371\/journal.pone.0088319","volume":"9","author":"K Yamahara","year":"2014","unstructured":"Yamahara K, Harada K, Ohshima M, Ishikane S, Ohnishi S, Tsuda H, et al. Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells. PLoS One. 2014;9:e88319.","journal-title":"PLoS One"},{"key":"3379_CR190","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/sctm.20-0390","volume":"10","author":"E Ragni","year":"2021","unstructured":"Ragni E, Papait A, Perucca Orfei C, Silini AR, Colombini A, Vigan\u00f2 M, et al. Amniotic membrane-mesenchymal stromal cells secreted factors and extracellular vesicle-miRNAs: anti-inflammatory and regenerative features for musculoskeletal tissues. Stem Cells Transl Med. 2021;10:1044\u201362.","journal-title":"Stem Cells Transl Med"},{"key":"3379_CR191","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/0963689717725078","volume":"27","author":"L Centurione","year":"2018","unstructured":"Centurione L, Passaretta F, Centurione MA, Munari S, Vertua E, Silini A, et al. Mapping of the human placenta: experimental evidence of amniotic epithelial cell heterogeneity. Cell Transplant. 2018;27:12\u201322.","journal-title":"Cell Transplant"},{"key":"3379_CR192","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1097\/01.TP.0000144606.84234.49","volume":"78","author":"M Bailo","year":"2004","unstructured":"Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, Lombardi G, et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation. 2004;78:1439\u201348.","journal-title":"Transplantation"},{"key":"3379_CR193","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.placenta.2008.09.009","volume":"30","author":"S Ilancheran","year":"2009","unstructured":"Ilancheran S, Moodley Y, Manuelpillai U. Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta. 2009;30:2\u201310.","journal-title":"Placenta"},{"key":"3379_CR194","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/jbm.b.33141","volume":"102","author":"TJ Koob","year":"2014","unstructured":"Koob TJ, Lim JJ, Massee M, Zabek N, Denozi\u00e8re G. Properties of dehydrated human amnion\/chorion composite grafts: implications for wound repair and soft tissue regeneration. J Biomed Mater Res B Appl Biomater. 2014;102:1353\u201362.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"3379_CR195","doi-asserted-by":"publisher","first-page":"23544","DOI":"10.1038\/srep23544","volume":"6","author":"A Kwon","year":"2016","unstructured":"Kwon A, Kim Y, Kim M, Kim J, Choi H, Jekarl DW, et al. Tissue-specific differentiation potency of mesenchymal stromal cells from perinatal tissues. Sci Rep. 2016;6:23544.","journal-title":"Sci Rep"},{"key":"3379_CR196","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/wound.2016.0699","volume":"6","author":"J Lei","year":"2017","unstructured":"Lei J, Priddy LB, Lim JJ, Massee M, Koob TJ. Identification of extracellular matrix components and biological factors in micronized dehydrated human amnion\/chorion membrane. Adv Wound Care (New Rochelle). 2017;6:43\u201353.","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"3379_CR197","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13287-020-01690-y","volume":"11","author":"X Yi","year":"2020","unstructured":"Yi X, Chen F, Liu F, Peng Q, Li Y, Li S, et al. Comparative separation methods and biological characteristics of human placental and umbilical cord mesenchymal stem cells in serum-free culture conditions. Stem Cell Res Ther. 2020;11:183.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR198","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/jcb.23395","volume":"113","author":"CY Fong","year":"2012","unstructured":"Fong CY, Gauthaman K, Cheyyatraivendran S, Lin HD, Biswas A, Bongso A. Human umbilical cord Wharton\u2019s jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo. J Cell Biochem. 2012;113:658\u201368.","journal-title":"J Cell Biochem"},{"key":"3379_CR199","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.biocel.2012.12.001","volume":"45","author":"M Choi","year":"2013","unstructured":"Choi M, Lee HS, Naidansaren P, Kim HK, Eunju O, Cha JH, et al. Proangiogenic features of Wharton\u2019s jelly-derived mesenchymal stromal\/stem cells and their ability to form functional vessels. Int J Biochem Cell Biol. 2013;45:560\u201370.","journal-title":"Int J Biochem Cell Biol"},{"key":"3379_CR200","doi-asserted-by":"publisher","first-page":"e72604","DOI":"10.1371\/journal.pone.0072604","volume":"8","author":"JY Hsieh","year":"2013","unstructured":"Hsieh JY, Wang HW, Chang SJ, Liao KH, Lee IH, Lin WS, et al. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One. 2013;8:e72604.","journal-title":"PLoS One"},{"key":"3379_CR201","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3727\/096368912X662444","volume":"22","author":"LR Gao","year":"2013","unstructured":"Gao LR, Zhang NK, Ding QA, Chen HY, Hu X, Jiang S, et al. Common expression of stemness molecular markers and early cardiac transcription factors in human Wharton\u2019s jelly-derived mesenchymal stem cells and embryonic stem cells. Cell Transplant. 2013;22:1883\u2013900.","journal-title":"Cell Transplant"},{"key":"3379_CR202","first-page":"1235","volume":"28","author":"S Corrao","year":"2013","unstructured":"Corrao S, La Rocca G, Lo Iacono M, Corsello T, Farina F, Anzalone R. Umbilical cord revisited: from Wharton\u2019s jelly myofibroblasts to mesenchymal stem cells. Histol Histopathol. 2013;28:1235\u201344.","journal-title":"Histol Histopathol"},{"key":"3379_CR203","doi-asserted-by":"publisher","first-page":"e92129","DOI":"10.1371\/journal.pone.0092129","volume":"9","author":"G Zhang","year":"2014","unstructured":"Zhang G, Zou X, Miao S, Chen J, Du T, Zhong L, et al. The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2\/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats. PLoS One. 2014;9:e92129.","journal-title":"PLoS One"},{"key":"3379_CR204","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10456-014-9432-7","volume":"17","author":"SS Edwards","year":"2014","unstructured":"Edwards SS, Zavala G, Prieto CP, Elliott M, Mart\u00ednez S, Ega\u00f1a JT, et al. Functional analysis reveals angiogenic potential of human mesenchymal stem cells from Wharton\u2019s jelly in dermal regeneration. Angiogenesis. 2014;17:851\u201366.","journal-title":"Angiogenesis"},{"key":"3379_CR205","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3390\/ijms20081807","volume":"20","author":"A Musia\u0142-Wysocka","year":"2019","unstructured":"Musia\u0142-Wysocka A, Kot M, Su\u0142kowski M, Badyra B, Majka M. Molecular and functional verification of Wharton\u2019s Jelly mesenchymal stem cells (WJ-MSCs) pluripotency. Int J Mol Sci. 2019;20:1807.","journal-title":"Int J Mol Sci"},{"key":"3379_CR206","first-page":"1099","volume":"86","author":"K Mareschi","year":"2001","unstructured":"Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica. 2001;86:1099\u2013100.","journal-title":"Haematologica"},{"key":"3379_CR207","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1089\/scd.2014.0490","volume":"24","author":"MR Todeschi","year":"2015","unstructured":"Todeschi MR, El Backly R, Capelli C, Daga A, Patrone E, Introna M, et al. Transplanted umbilical cord mesenchymal stem cells modify the in vivo microenvironment enhancing angiogenesis and leading to bone regeneration. Stem Cells Dev. 2015;24:1570\u201381.","journal-title":"Stem Cells Dev"},{"key":"3379_CR208","doi-asserted-by":"publisher","first-page":"513","DOI":"10.5966\/sctm.2014-0267","volume":"4","author":"B Zhang","year":"2015","unstructured":"Zhang B, Wu X, Zhang X, Sun Y, Yan Y, Shi H, et al. Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4\/beta-catenin pathway. Stem Cells Transl Med. 2015;4:513\u201322.","journal-title":"Stem Cells Transl Med"},{"key":"3379_CR209","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13287-019-1405-8","volume":"10","author":"Q Huang","year":"2019","unstructured":"Huang Q, Yang Y, Luo C, Wen Y, Liu R, Li S, et al. An efficient protocol to generate placental chorionic plate-derived mesenchymal stem cells with superior proliferative and immunomodulatory properties. Stem Cell Res Ther. 2019;10:301.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR210","doi-asserted-by":"publisher","first-page":"e43395","DOI":"10.1371\/journal.pone.0043395","volume":"7","author":"GN Jones","year":"2012","unstructured":"Jones GN, Moschidou D, Puga-Iglesias TI, Kuleszewicz K, Vanleene M, Shefelbine SJ, et al. Ontological differences in first compared to third trimester human fetal placental chorionic stem cells. PLoS One. 2012;7:e43395.","journal-title":"PLoS One"},{"key":"3379_CR211","doi-asserted-by":"publisher","first-page":"e68451","DOI":"10.1371\/journal.pone.0068451","volume":"8","author":"C Salomon","year":"2013","unstructured":"Salomon C, Ryan J, Sobrevia L, Kobayashi M, Ashman K, Mitchell M, et al. Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One. 2013;8:e68451.","journal-title":"PLoS One"},{"key":"3379_CR212","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12015-014-9562-8","volume":"11","author":"FM Abomaray","year":"2015","unstructured":"Abomaray FM, Al Jumah MA, Kalionis B, AlAskar AS, Al Harthy S, Jawdat D, et al. Human chorionic villous mesenchymal stem cells modify the functions of human dendritic cells, and induce an anti-inflammatory phenotype in CD1+ dendritic cells. Stem Cell Rev Rep. 2015;11:423\u201341.","journal-title":"Stem Cell Rev Rep"},{"key":"3379_CR213","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10561-016-9559-4","volume":"17","author":"E Katsiani","year":"2016","unstructured":"Katsiani E, Garas A, Skentou C, Tsezou A, Messini CI, Dafopoulos K, et al. Chorionic villi derived mesenchymal like stem cells and expression of embryonic stem cells markers during long-term culturing. Cell Tissue Bank. 2016;17:517\u201329.","journal-title":"Cell Tissue Bank"},{"key":"3379_CR214","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13287-016-0297-0","volume":"7","author":"W Du","year":"2016","unstructured":"Du W, Li X, Chi Y, Ma F, Li Z, Yang S, et al. VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity. Stem Cell Res Ther. 2016;7:49.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR215","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-213X-13-34","volume":"13","author":"D Lai","year":"2013","unstructured":"Lai D, Wang F, Chen Y, Wang L, Wang Y, Cheng W. Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility. BMC Dev Biol. 2013;13:34.","journal-title":"BMC Dev Biol"},{"key":"3379_CR216","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3727\/096368914X678553","volume":"23","author":"I Antonucci","year":"2014","unstructured":"Antonucci I, Di Pietro R, Alfonsi M, Centurione MA, Centurione L, Sancilio S, et al. Human second trimester amniotic fluid cells are able to create embryoid body-like structures in vitro and to show typical expression profiles of embryonic and primordial germ cells. Cell Transplant. 2014;23:1501\u201315.","journal-title":"Cell Transplant"},{"key":"3379_CR217","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jcb.22453","volume":"109","author":"P Huang","year":"2010","unstructured":"Huang P, Lin LM, Wu XY, Tang QL, Feng XY, Lin GY, et al. Differentiation of human umbilical cord Wharton\u2019s jelly-derived mesenchymal stem cells into germ-like cells in vitro. J Cell Biochem. 2010;109:747\u201354.","journal-title":"J Cell Biochem"},{"key":"3379_CR218","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00418-012-0975-7","volume":"138","author":"P Qiu","year":"2012","unstructured":"Qiu P, Bai Y, Liu C, He X, Cao H, Li M, et al. A dose-dependent function of follicular fluid on the proliferation and differentiation of umbilical cord mesenchymal stem cells (MSCs) of goat. Histochem Cell Biol. 2012;138:593\u2013603.","journal-title":"Histochem Cell Biol"},{"key":"3379_CR219","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/cbf.2981","volume":"31","author":"P Qiu","year":"2013","unstructured":"Qiu P, Bai Y, Pan S, Li W, Liu W, Hua J. Gender depended potentiality of differentiation of human umbilical cord mesenchymal stem cells into oocyte-like cells in vitro. Cell Biochem Funct. 2013;31:365\u201373.","journal-title":"Cell Biochem Funct"},{"key":"3379_CR220","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/cpr.12115","volume":"47","author":"N Li","year":"2014","unstructured":"Li N, Pan S, Zhu H, Mu H, Liu W, Hua J. BMP4 promotes SSEA-1(+) hUC-MSC differentiation into male germ-like cells in vitro. Cell Prolif. 2014;47:299\u2013309.","journal-title":"Cell Prolif"},{"key":"3379_CR221","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jcyt.2013.10.015","volume":"16","author":"M Kaviani","year":"2014","unstructured":"Kaviani M, Ezzatabadipour M, Nematollahi-Mahani SN, Salehinejad P, Mohammadi M, Kalantar SM, et al. Evaluation of gametogenic potential of vitrified human umbilical cord Wharton\u2019s jelly-derived mesenchymal cells. Cytotherapy. 2014;16:203\u201312.","journal-title":"Cytotherapy"},{"key":"3379_CR222","first-page":"218","volume":"6","author":"M Latifpour","year":"2014","unstructured":"Latifpour M, Shakiba Y, Amidi F, Mazaheri Z, Sobhani A. Differentiation of human umbilical cord matrix-derived mesenchymal stem cells into germ-like cells. Avicenna J Med Biotechnol. 2014;6:218\u201327.","journal-title":"Avicenna J Med Biotechnol"},{"key":"3379_CR223","first-page":"325","volume":"18","author":"NA Nejad","year":"2015","unstructured":"Nejad NA, Amidi F, Hoseini MA, Nia KN, Habibi M, Kajbafzadeh AM, et al. Male germ-like cell differentiation potential of human umbilical cord Wharton\u2019s jelly-derived mesenchymal stem cells in co-culture with human placenta cells in presence of BMP4 and retinoic acid. Iran J Basic Med Sci. 2015;18:325\u201333.","journal-title":"Iran J Basic Med Sci"},{"key":"3379_CR224","first-page":"22","volume":"18","author":"HR Asgari","year":"2015","unstructured":"Asgari HR, Akbari M, Abbasi M, Ai J, Korouji M, Aliakbari F, et al. Human Wharton\u2019s jelly-derived mesenchymal stem cells express oocyte developmental genes during co-culture with placental cells. Iran J Basic Med Sci. 2015;18:22\u20139.","journal-title":"Iran J Basic Med Sci"},{"key":"3379_CR225","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3892\/ijmm.2015.2132","volume":"35","author":"X Hu","year":"2015","unstructured":"Hu X, Lu H, Cao S, Deng YL, Li QJ, Wan Q, et al. Stem cells derived from human first-trimester umbilical cord have the potential to differentiate into oocyte-like cells in vitro. Int J Mol Med. 2015;35:1219\u201329.","journal-title":"Int J Mol Med"},{"key":"3379_CR226","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40001-014-0080-6","volume":"20","author":"L Xie","year":"2015","unstructured":"Xie L, Lin L, Tang Q, Li W, Huang T, Huo X, et al. Sertoli cell-mediated differentiation of male germ cell-like cells from human umbilical cord Wharton\u2019s jelly-derived mesenchymal stem cells in an in vitro co-culture system. Eur J Med Res. 2015;20:9.","journal-title":"Eur J Med Res"},{"key":"3379_CR227","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s11626-015-9929-4","volume":"51","author":"F Amidi","year":"2015","unstructured":"Amidi F, Ataie Nejad N, Agha Hoseini M, Nayernia K, Mazaheri Z, Yamini N, et al. In vitro differentiation process of human Wharton\u2019s jelly mesenchymal stem cells to male germ cells in the presence of gonadal and non-gonadal conditioned media with retinoic acid. In Vitro Cell Dev Biol Anim. 2015;51:1093\u2013101.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"3379_CR228","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cpr.12236","volume":"49","author":"B Li","year":"2016","unstructured":"Li B, Liu W, Zhuang M, Li N, Wu S, Pan S, et al. Overexpression of CD61 promotes hUC-MSC differentiation into male germ-like cells. Cell Prolif. 2016;49:36\u201347.","journal-title":"Cell Prolif"},{"key":"3379_CR229","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/and.12887","volume":"50","author":"R Ghaem Maghami","year":"2018","unstructured":"Ghaem Maghami R, Mirzapour T, Bayrami A. Differentiation of mesenchymal stem cells to germ-like cells under induction of Sertoli cell-conditioned medium and retinoic acid. Andrologia. 2018;50:3.","journal-title":"Andrologia"},{"key":"3379_CR230","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5653\/cerm.2018.45.2.75","volume":"45","author":"D Dissanayake","year":"2018","unstructured":"Dissanayake D, Patel H, Wijesinghe PS. Differentiation of human male germ cells from Wharton\u2019s jelly-derived mesenchymal stem cells. Clin Exp Reprod Med. 2018;45:75\u201381.","journal-title":"Clin Exp Reprod Med"},{"key":"3379_CR231","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbrc.2019.04.059","volume":"514","author":"A Babaee","year":"2019","unstructured":"Babaee A, Nematollahi-Mahani SN, Dehghani-Soltani S, Shojaei M, Ezzatabadipour M. Photobiomodulation and gametogenic potential of human Wharton\u2019s jelly-derived mesenchymal cells. Biochem Biophys Res Commun. 2019;514:239\u201345.","journal-title":"Biochem Biophys Res Commun"},{"key":"3379_CR232","doi-asserted-by":"publisher","first-page":"e04992","DOI":"10.1016\/j.heliyon.2020.e04992","volume":"6","author":"M Zolfaghar","year":"2020","unstructured":"Zolfaghar M, Mirzaeian L, Beiki B, Naji T, Moini A, Eftekhari-Yazdi P, et al. Wharton\u2019s jelly derived mesenchymal stem cells differentiate into oocyte like cells in vitro by follicular fluid and cumulus cells conditioned medium. Heliyon. 2020;6:e04992.","journal-title":"Heliyon"},{"key":"3379_CR233","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/ahe.12537","volume":"49","author":"F Majidi","year":"2020","unstructured":"Majidi F, Bamehr H, Shalchian Z, Kouchakian MR, Mohammadzadeh N, Khalili A. Differentiation of human umbilical cord mesenchymal stem cell into germ-like cell under effect of co-culture with testicular cell tissue. Anat Histol Embryol. 2020;49:359\u201364.","journal-title":"Anat Histol Embryol"},{"key":"3379_CR234","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s13770-020-00309-w","volume":"18","author":"HF Ibrahim","year":"2021","unstructured":"Ibrahim HF, Safwat SH, Zeitoun TM, El Mulla KF, Medwar AY. The therapeutic potential of amniotic fluid-derived stem cells on busulfan-induced azoospermia in adult rats. Tissue Eng Regen Med. 2021;18:279\u201395.","journal-title":"Tissue Eng Regen Med"},{"key":"3379_CR235","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fphar.2020.00272","volume":"11","author":"B Huang","year":"2020","unstructured":"Huang B, Ding C, Zou Q, Lu J, Wang W, Li H. Human amniotic fluid mesenchymal stem cells improve ovarian function during physiological aging by resisting DNA damage. Front Pharmacol. 2020;11:272.","journal-title":"Front Pharmacol"},{"key":"3379_CR236","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13287-017-0613-3","volume":"8","author":"C Ding","year":"2017","unstructured":"Ding C, Li H, Wang Y, Wang F, Wu H, Chen R, et al. Different therapeutic effects of cells derived from human amniotic membrane on premature ovarian aging depend on distinct cellular biological characteristics. Stem Cell Res Ther. 2017;8:173.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR237","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13287-017-0739-3","volume":"8","author":"L Ling","year":"2017","unstructured":"Ling L, Feng X, Wei T, Wang Y, Wang Y, Zhang W, et al. Effects of low-intensity pulsed ultrasound (LIPUS)-pretreated human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on primary ovarian insufficiency in rats. Stem Cell Res Ther. 2017;8:283.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR238","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13287-019-1136-x","volume":"10","author":"L Ling","year":"2019","unstructured":"Ling L, Feng X, Wei T, Wang Y, Wang Y, Wang Z, et al. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism. Stem Cell Res Ther. 2019;10:46.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR239","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13287-020-01803-7","volume":"11","author":"C Qian","year":"2020","unstructured":"Qian C, Meng Q, Lu J, Zhang L, Li H, Huang B. Human amnion mesenchymal stem cells restore spermatogenesis in mice with busulfan-induced testis toxicity by inhibiting apoptosis and oxidative stress. Stem Cell Res Ther. 2020;11:290.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR240","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13287-017-0721-0","volume":"8","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Bu S, Sun J, Xu M, Yao X, He K, et al. Paracrine effects of human amniotic epithelial cells protect against chemotherapy-induced ovarian damage. Stem Cell Res Ther. 2017;8:270.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR241","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.omtn.2019.03.008","volume":"16","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Sun J, Huang Y, Bu S, Guo Y, Gu T, et al. Human amniotic epithelial cell-derived exosomes restore ovarian function by transferring microRNAs against apoptosis. Mol Ther Nucleic Acids. 2019;16:407\u201318.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3379_CR242","doi-asserted-by":"publisher","first-page":"698","DOI":"10.4103\/1008-682X.129209","volume":"16","author":"RF Yang","year":"2014","unstructured":"Yang RF, Liu TH, Zhao K, Xiong CL. Enhancement of mouse germ cell-associated genes expression by injection of human umbilical cord mesenchymal stem cells into the testis of chemical-induced azoospermic mice. Asian J Androl. 2014;16:698\u2013704.","journal-title":"Asian J Androl"},{"key":"3379_CR243","doi-asserted-by":"publisher","first-page":"2517514","DOI":"10.1155\/2016\/2517514","volume":"2016","author":"D Song","year":"2016","unstructured":"Song D, Zhong Y, Qian C, Zou Q, Ou J, Shi Y, et al. Human umbilical cord mesenchymal stem cells therapy in cyclophosphamide-induced premature ovarian failure rat model. Biomed Res Int. 2016;2016:2517514.","journal-title":"Biomed Res Int"},{"key":"3379_CR244","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13287-017-0685-0","volume":"8","author":"Z Li","year":"2017","unstructured":"Li Z, Zhang Z, Chen X, Zhou J, Xiao XM. Treatment evaluation of Wharton\u2019s jelly-derived mesenchymal stem cells using a chronic salpingitis model: an animal experiment. Stem Cell Res Ther. 2017;8:232.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR245","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/s41598-017-02786-x","volume":"7","author":"L Sun","year":"2017","unstructured":"Sun L, Li D, Song K, Wei J, Yao S, Li Z, et al. Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin-induced ovarian granulosa cell stress and apoptosis in vitro. Sci Rep. 2017;7:2552.","journal-title":"Sci Rep"},{"key":"3379_CR246","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13287-019-1327-5","volume":"10","author":"Z Yang","year":"2019","unstructured":"Yang Z, Du X, Wang C, Zhang J, Liu C, Li Y, et al. Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice. Stem Cell Res Ther. 2019;10:250.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR247","doi-asserted-by":"publisher","first-page":"3249495","DOI":"10.1155\/2020\/3249495","volume":"2020","author":"Z Wang","year":"2020","unstructured":"Wang Z, Wei Q, Wang H, Han L, Dai H, Qian X, et al. Mesenchymal stem cell therapy using human umbilical cord in a rat model of autoimmune-induced premature ovarian failure. Stem Cells Int. 2020;2020:3249495.","journal-title":"Stem Cells Int"},{"key":"3379_CR248","doi-asserted-by":"publisher","first-page":"963689720923575","DOI":"10.1177\/0963689720923575","volume":"29","author":"C Liu","year":"2020","unstructured":"Liu C, Yin H, Jiang H, Du X, Wang C, Liu Y, et al. Extracellular vesicles derived from mesenchymal stem cells recover fertility of premature ovarian insufficiency mice and the effects on their offspring. Cell Transplant. 2020;29:963689720923575.","journal-title":"Cell Transplant"},{"key":"3379_CR249","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/jmcb\/mjz105","volume":"12","author":"L Hong","year":"2020","unstructured":"Hong L, Yan L, Xin Z, Hao J, Liu W, Wang S, et al. Protective effects of human umbilical cord mesenchymal stem cell-derived conditioned medium on ovarian damage. J Mol Cell Biol. 2020;12:372\u201385.","journal-title":"J Mol Cell Biol"},{"key":"3379_CR250","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/09513590.2021.1878133","volume":"37","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang L, Li Y, Yin Z, Feng Y, Ji Y. Human umbilical cord mesenchymal stem cells (hUCMSCs) promotes the recovery of ovarian function in a rat model of premature ovarian failure (POF). Gynecol Endocrinol. 2021;37:353\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"3379_CR251","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11010-016-2928-2","volume":"428","author":"SH Abd Allah","year":"2017","unstructured":"Abd Allah SH, Pasha HF, Abdelrahman AA, Mazen NF. Molecular effect of human umbilical cord blood CD34-positive and CD34-negative stem cells and their conjugate in azoospermic mice. Mol Cell Biochem. 2017;428:179\u201391.","journal-title":"Mol Cell Biochem"},{"key":"3379_CR252","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/biomedicines7010007","volume":"7","author":"SA Mohamed","year":"2019","unstructured":"Mohamed SA, Shalaby S, Brakta S, Elam L, Elsharoud A, Al-Hendy A. Umbilical cord blood mesenchymal stem cells as an infertility treatment for chemotherapy induced premature ovarian insufficiency. Biomedicines. 2019;7:7.","journal-title":"Biomedicines"},{"key":"3379_CR253","doi-asserted-by":"publisher","first-page":"151658","DOI":"10.1016\/j.acthis.2020.151658","volume":"123","author":"L Jalalie","year":"2021","unstructured":"Jalalie L, Rezaee MA, Rezaie MJ, Jalili A, Raoofi A, Rustamzade A. Human umbilical cord mesenchymal stem cells improve morphometric and histopathologic changes of cyclophosphamide-injured ovarian follicles in mouse model of premature ovarian failure. Acta Histochem. 2021;123:151658.","journal-title":"Acta Histochem"},{"key":"3379_CR254","doi-asserted-by":"publisher","first-page":"15313","DOI":"10.1038\/s41598-018-33575-9","volume":"8","author":"TH Kim","year":"2018","unstructured":"Kim TH, Choi JH, Jun Y, Lim SM, Park S, Paek JY, et al. 3D-cultured human placenta-derived mesenchymal stem cell spheroids enhance ovary function by inducing folliculogenesis. Sci Rep. 2018;8:15313.","journal-title":"Sci Rep"},{"key":"3379_CR255","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13287-018-0819-z","volume":"9","author":"J Li","year":"2018","unstructured":"Li J, Yu Q, Huang H, Deng W, Cao X, Adu-Frimpong M, et al. Human chorionic plate-derived mesenchymal stem cells transplantation restores ovarian function in a chemotherapy-induced mouse model of premature ovarian failure. Stem Cell Res Ther. 2018;9:81.","journal-title":"Stem Cell Res Ther"},{"key":"3379_CR256","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/cbin.11165","volume":"43","author":"H Li","year":"2019","unstructured":"Li H, Zhao W, Wang L, Luo Q, Yin N, Lu X, et al. Human placenta-derived mesenchymal stem cells inhibit apoptosis of granulosa cells induced by IRE1\u03b1 pathway in autoimmune POF mice. Cell Biol Int. 2019;43:899\u2013909.","journal-title":"Cell Biol Int"},{"key":"3379_CR257","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/antiox9070591","volume":"9","author":"J Seok","year":"2020","unstructured":"Seok J, Park H, Choi JH, Lim JY, Kim KG, Kim GJ. Placenta-derived mesenchymal stem cells restore the ovary function in an ovariectomized rat model via an antioxidant effect. Antioxidants (Basel). 2020;9:591.","journal-title":"Antioxidants (Basel)"},{"key":"3379_CR258","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13287-021-02275-z","volume":"12","author":"J Lu","year":"2021","unstructured":"Lu J, Liu Z, Shu M, Zhang L, Xia W, Tang L, et al. Human placental mesenchymal stem cells ameliorate chemotherapy-induced damage in the testis by reducing apoptosis\/oxidative stress and promoting autophagy. Stem Cell Res Ther. 2021;12:199.","journal-title":"Stem Cell Res Ther"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03379-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03379-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03379-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T15:11:51Z","timestamp":1702566711000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03379-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":258,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3379"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03379-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]},"assertion":[{"value":"6 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}